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1INTRODUCTION
2INTRODUCTION
CVD is an important health problem world wide, with annual incidence
of 0.2 to 2.5 per 1000 population. CVD of ischemic origin is one of the major
causes for disability and death. Parameters of ischaemic stroke for predicting
outcome in the disease process, such patients have not been clearly identified in
the Indian population. Various studies proved that CRP and Troponin T at
admission was found to predict the poor functional disability in ischemic stroke.
Acute occlusion of a cerebral vessel causes reduced blood
flow to the region in the brain it supplies. stroke syndrome are divided in to
1. Large vessel stroke involving anterior cirulation
2. Large vessel stroke involving posterior circulation.
3. Small vessel diseases
STROKE IN THE ANTERIOR CIRCULATION
Anterior circulation comprises of internal carotid artery and its branches.
These vessels can be occluded by embolic or atherosclerosis and dissection
occlusion from a proximal source.
3MIDDLE CEREBRAL ARTERY (MCA):
Proximal MCA occlusion or its branches are cuased by an embolus of
cardiac origin or of some unknown origin rather than intra cranial thrombosis.
Because atherothrombosis of middle cerebral artery will be slowly progressive
by the time it is significant in size effective collaterals would have developed
which prevents MCA insufficiency from becoming apparent and symptomatic.
MCA branches that supply the supero medial border of the parietal and
frontal lobes that is on its lateral surface supplied by the Anterior cerebral
arteries (ACA). The lower occipital and temporal lobe convolutions. The M1
segment , proximal part of MCA, gives rise to the penetrating branches to the
brain called lenticulostriate arteries supplying the posterior limb of the internal
capsule, putamen, outer globus pallidus, most of the caudate nucleus and
corona radiate.
The MCA after M1 segment, divides into  inferior and superior divisions
in the sylvian fissure, called M2 branches. The superior division supplies the
frontal cortex and superior parietal cortex and the inferior division supplies the
temporal and inferior parietal cortex.
In entire occlusion of MCA, the clinical findings are hemianesthesia
homonymous hemianopia, and a gaze preference to ipsilateral side for a day or
two along with contralateral hemiplegia. Global aphasia constructional apraxia,
4anosognosia may also be present. Dysarthria is common becaue of facial nerve
weakness.
Lenticulostriate arteries are small vessels when occluded stroke within
the internal capsule may produce sensory motor stroke or pure motor stroke on
the contralateral side. When genu of the internal capsule involved causes facial
weakness primarily followed by arm then leg weakness as the ischaemia
progresses posteriorly within the internal capsule.
ANTERIOR CEREBRAL ARTERY (ACA)
ACA is divided into
1. Precommunal circle of Willis A1 (proximal to anterior communicating
artery)
2. Postcommunal A2 (distal to the anterior communicating artery)
A1 supplies the internal capsule – its anterior limb, anterior
hypothalamus, anterior perforate substance, head of the caudate nucleus in its
inferior part and amygdala. A1 branch occlusion is tolerated well because of the
presence of anterior communicating artery. But occlusion of A2 results in contra
lateral symptoms of urinary incontinence, motor involvement of leg arm. When
both A2 are occluded profound abulia occurs.
5ANTERIOR CHOROIDAL ARTERY:
Anterior choroidal artery arises from internal carotid artery that supplies
the posterior limb of internal capsule with the white matter posterior to it and
some geniculocalcarine fibres. Occlusion of anterior choroidal artery results in
contalateral hemiplegia, hemianesthesia and homonymous hemianopia
INTERNAL CAROTID ARTERY:
Clinical pattern of occlusion of internal carotid artery varies
depending upon the cause of ischaemia – low flow, embolism or propagated
thrombus. MCA territory is most affected.
COMMON CAROTID ARTERY:
In common carotid artery occlusion all the clinical features of occlusion
of internal carotid artery will be present along with claudicating of jaw because
of occlusion of external carotid artery. Bilateral common carotid artery
occlusion may occur in Takayasu’s areteritis.
POSTERIOR CIRCULATION STROKE:
Posterior circulation includes
1. Vertebral arteries on both sides
2. Basilar artery is formed by joining of  vertebral arteries on both sides.
63. And two posterior cerebral arteries formed by division of basilar artery
in to two.
VERTEBRAL AND POSTERIOR INFERIOR CEREBELLAR ARTERIES:
The vertebral artery consists of four different segments, V1 from origin to
its entry in to the vertebra foramenat C6 or C5, V2 from C6 to C2, V3 from
winds around the arch of Atlas to pierce the duramater at foramen magnum
entering brain and V4 runs uptwrads and joins to form basilar artery. Occlusion
of V4 causes lateral medullary syndrome - the ishaemia of lateral part of
medulla and causes vertigo, numbness of ipsilateral face and contralateral
limbs, diplopia, ipsilateral Horner’s syndrome. Hemiparesis will not occur in
vertebral artery occlusion but quadriparesis can occur because of anterior spinal
artery occlusion. Rarely medial medullary syndrome can occur. When
cerebellum is involved sudden respiratory paralysis may occur.
BASILAR ARTERY:
Supplies the superior cerebellum and base of pons. There are 3 groups
paramedian, short circumferential, and long circumferential bilaterally (anterior
inferior and superior cerebellar) arteries. Complete basilar artery occlusion
causes bilateral long tract sign with signs of cranial nerve palsies with cerebellar
dysfunction. Occlusion of superior cerebellar artery results in severe cerebellar
ataxia, nausea and vomiting, dysarthria and contralateral hemianesthesia over
7the extremities, body and face. Occlusion of anterior inferior cerebellar artery
produces facial weakness, vertigo, nausea, and vomiting, tinnitus, ipsilateral
deafness, nystagmus, cerebellar ataxia, Horner’s syndrome and conjugate lateral
gaze palsy, contralateral hemianesthesia.
POSTERIOR CEREBRAL ARTERY:
In posterior cerebral artery occlusion two clinical syndrome can be seen
1. P1 syndrome:
Proximal segment of the PCA occlusion causes infarction  in the
medial thalamus and ipsilateral subthalamus, midbrain and in the
ipsilateral cerebral peduncle. A  3rd nerve palsy with contralateral
ataxia called Claudes’s syndrome can occur or with contralateral
hemiplegia called Weber’s syndromecan occur.
2. P2 syndrome:
Distal PCA occlusion causes infarction in the occipital and medial
temporal lobes. Contralateral homonymous hemianopia with
macular sparing is the ususal presentation.
8Inflammation plays an important role in the pathogenesis of cerebro
vascular, cardiovascular acute athero thrombotic events it also activates the
production of the many acute phase proteins like C-reactive protein(CRP),
serum amyloid A and fibrinogen.
The CRP concentration in serum, may increase more than thousand times
upon inflammation and with a half life of 19 hrs and it is an independent
predictor of risk of cardiovascular events, atherosclerosis, atherothrombosis,
myocardial infarction and hypertension.
Of many kinds of inflammatory markers, studies show CRP may be the
most powerful inflammatory predictor of poor prognosis in cardiovascular and
cerebrovascular events.
Also patient with elevated CRP levels within 72 hrs of stroke have an
increased risk of mortality.
CRP in ischemic stroke predicts outcome and identifies patients who are
at risk for future vascular events and early mortality.
CRP has also been found to be elevated in patients with ischemic stroke,
correlating with the size of the infarct as evidenced by ct scan atherosclerosis is
a multifactorial disease ,caused by the underlying inflammation. This
inflammatory process also contributes to the pathogenesis of acute thrombotic
events. CRP is an acute phase reactant and its level in the body is directly
9proprortional to the level of inflammation in the body. Increased levels of CRP
are consistently associated with increased cardiovascular disease and predict
poor prognosis in myocardial infarctions and stroke.
Thus CRP is useful and reliable predictor of cerebrovascular events. Also
cardiac activity is also affected by stroke. Particularly stroke involving insular
cortex causes dysrythmia and also there are theories many micro emboli
occluding the coronary arteries causeing myocardial damage which gives rise to
elevated levels of serum cardiac specific troponin T. this myocardial injuty
associated with ischemic stroke have a profound impact on the outcome of the
morbidity in stroke patients. Thus troponin T and CRP (hsCRP) can be used as
predictor of morbidity in cerebrovascular events
10
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AIMS AND OBJECTIVES
AIM OF THE STUDY
1. To evaluate the role of hsCRP and troponin T as a morbidity predictor in
acute ischemic stroke
2. To study the CRP level pattern and troponin T level pattern in ischemic
stroke.
3. To study the correlation between severity level of stroke and CRP and
troponin T level individually and in combination of both values.
12
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STROKE
DEFINITION
Stroke or CVD is a acute onset of clinical symptoms and signs of focal or
global (from just facial palsy or arm weakness to complete paralysis or
coma) loss of cerebral function, with lasting for more than 48 hours and
leading to death with no obvious cause, other than that of atherogenic
vascular occlusion.
Cerebral infarction accounts for apparently 80% of stoke as opposed to
10% due to primary intra cerebral bleed, 5% due to sub arachnoid
hemorrhage and 5% of uncertain etiology.
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PATHOLOGICAL TYPE %
CEREBRAL INFARCTION
1. Large vessel occlusion
2. Small large vessel occlusion(lacunar infarct)
3. Cardiac emboli
4. Hematological disorder vasculitides
5. Vasculopathy
80%
PRIMARY INTRACEREBRAL HAEMORRHAGE
1. Hypertensive bleeds
2. Vascular malformation
3. Bleeding diathesis anticoagulation
10%
Non traumatic SAH
Aneurysm vascular malformation
Non aneurysmal SAH
5%
Other causes 5%
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CAUSES OF CEREBRAL ISCHAEMIA AND INFARCTION
1. Arterial wall disorders Athero thrombo embolism intra cranial small
vessel disease (lipohyalinosis, micro atheroma)
trauma, dissection, fibro muscular dysplasia,
congenital altered wall anomalies, moyo-moyo
disease, embolism, inflammatory,
Binswanger’s disease, irradiations and
infections
2. Embolism from heart
3. Hematological
4. Miscellaneous Pregnancy, peripartum, OCP, drug abuse,
cancer, IBD,homocystinemia, hypoglycemia,
mitochondrial cytopathy, epidermal nerves,
snake bite, fat embolism, nephrotic syndrome
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RELATIVE IMPORTANT CAUSE OF ISCHEMIC STROKE
Athero thrombo embolism of cerebral arterial supply 50%
Lipohyalinosis / micro atheroma 25%
Embolism from heart 20%
Miscellaneous 5%
From above tables the following points are evident
1. Cerebral infarction accounts for 80%  of all strokes.
2. Athero thrombo embolism of cerebral arterial supply is the cause of
50% of causes of cerebral infarction.
RISK FACTORS FOR ISCHEMIC STROKE
I. Non modifiable risk factors
Age
Sex
Race
Family history
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II. Modifiable risk factors
Blood pressure
Diabetes mellitus
Hyper cholesterolemia
Smoking
Cardiovascular diseases
TIA
Carotid artery diseases
Drugs
Obesity
Diet
Exercise
Other risk factors
III. Newer risk factors
1. Infection / inflammation.
Both acute and chronic inflammation play a role in
development and stability of atheromatous plaques. There is now
evidence of association between stroke and serum CRP and
Troponin T levels.
2. Haemostatic variables
18
Homocystinemia
PATHOPHYSIOLOGY OF ISCHEMIC STROKE
There are two patho physiological process.
1. A loss of supply of oxygen and glucose secondary to vascular occlusion.
2. An variety of changes in intracellular metabolism as a result of the loss of
energy producing processes leading to disintegration of cell membrane
19
FOCAL CEEBRAL ISCHAEMIA
Release of
exitotoxins
Glutamate
Energy
production
Release of mediators of
inflammations and
cytokines
Glutamate
receptors
Ion pump
failure
Mitochondria
l injury
Generation of
oxygen free
radicals
CRP
Mitochondria
l damage
Prostaglandin
s leukotrienes
Stimulation
of proteases
Cell
membrane
injury
Arachnoidic
acid
leukotrienes
Free fatty
acids
Stimulation
of
phospholipid
s
Cellular
Na+/Ca+
influx
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PREDICTORS OF STROKE OUTCOME
Although there are promising therapies for acute ischemic stroke with
high expectation for rapid recovery and good outcome, poor outcome can still
occur.
This is so because; ischemic stroke is a heterogenous condition. Whose
outcome is influenced by many factors. The extent of brain injury and the result
of outcome from ischaemia is largely dictated at a physiological level by the
severity and duration of the insult. Demographic variables, risk factors, clinical
examination findings, lab test result and imaging studies provide important
insight regarding outcome.
DEMOGRAPHIC FACTORS:
1. Age:
One of the major factors that negatively influence the outcome for
patients with ischemic stroke. Older patients are less likely to improve
comparing to the younger patients with similar size infarcts. Poor
outcome can be explained by increased incidence of secondary
complications among elderly stroke patients and having high
incidence of other systemic diseases that preclude recovery.
21
2. Temperature:
Body temperature predicts and influences stroke outcome for each
10 Celsius increase in body temperature. The relative risk of poor
outcome raised two fold. One explanation for this is and increased
concentration of excitotoxic neurotransmitter.
While demographic and clinical findings have an established ray in
the predictors and prognostic indicator, lab findings have also been
found to play an important role.
3. I. high serum and CSF glutamate are common in patients with
progressive stroke. High level of glutamate or glycine, both of which are
excitotoxic neurotransmitters have strongly been related to large infarct
size and severe neurological deficit. CNS specific proteins have been
evaluated in blood, at the acute phase of ischemic stroke such as S100
and neuron specific enolase.
II. prognostic value of acute phase reactant such as ESR and
Two inflammatory markers also provide prognostic information.
1. ESR erythrocyte sedimentation rate
2. CRP
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and a serum level of Troponin T also have a prognostic information.
4. Gender:
Some studies have shown male sex associates with poorer outcome, while
some other studies have shown no difference. Probably hormonal protection
could be the reason as experiments on animals showed improving stroke.
5.  Cerebro Vascular Risk Factors:
Previous stroke and AF:
These are 2 major risk factors. Previous h/o stroke has been
consistently associated with higher likelihood of death or dependence
probably due to lower prestroke level of function and more advanced
cardio vascular disease. Stroke in patients with atrial fibrillation are
usually more severe, more disability and associated with high mortality.
6. Clinical Findings:
Level of consciousness and gaze deviation is generally associated with
poorer outcome.
7. Blood Pressure:
Abnormal BP may influence outcome. Clinical studies of BP reduction
have shown a decrease in cerebral blood flow to infarction area. On the other
23
hand, highly elevated BP has adverse long term effects in blood – brain barrier.
Hypertension has been found to play a role in haemorrhagic transformation.
8. ESR: erythrocyte sedimentation rate independently predicted shor term
outcome with increased level predicting poor outcome.
9. CRP:
an acute phase reactant has been found to predict outcome.
concentrations measured in 72 hours of stroke, independently predicted survival
after ischaemic stroke.
Inflammation plays an important part in the initiation, development and
progression of atherosclerosis and other systemic blood markers of
inflammation (i.e.) acute phase reactants such as  and fibrinogen have emerged
as powerful predictors of coronary and cerebrovascular events.
10. Troponin T: Serum levels of Troponin T was found to be an independent
predictor of morbidity in patients with acute ischaemic stroke.
24
PATHOGENESIS OF INFECTION / INFLAMMATION ASSOCIATED
WITH STROKE INVOLVES THE FOLLOWING
1. Increased fibrinogen.
2. Elastase released by activated granulocytes.
3. Inhibition of anticoagulation pathway involving with
a. Protein C
b. Protein S
c. Anti thrombin III
4. Release of inflammatory cytokines
a. TNF alpha
b. IL 1B
c. IL B
5. Increased CRP
6. Elevated Troponin T enzyme level
I. INFLAMMATION
Inflammation has an important part in the pathogenesis of acute athero
thrombotic events, cardiovascular events and atherosclerosis. It also
controls the production of many of the acute phase proteins such as
fibrinogen, serum amyloid A and CRP. The serum concentration of
CRP can increase more than thousand fold up on inflammation and
with half life 19 hours, is a very stable maker of the inflammatory
25
process because it is a very sensitive indicator of the underlying
inflammatory process, that it has been studied extensively, whether
plasma levels of CRP and other inflammatory proteins in circulation
(ex. Fibrinogen, IL 6) have a very high predictive value in the
pathogenesis and progression of CVD.
II. COMPONENTS OF THE ATHERSCLEROTIC LESION
Endothelial dysfunction is the first step in development of
atherosclerosis. These endothelial cells (EC’s) express the vascular
cell adhesion molecules (VCAM1). Intracellular adhesion molecule
(ICAM1) and the endothelial leucocyte adhesion molecule (ELAM1)
on the cell surface leucoytes, especially T lymphocytes (CD 8
cytotoxic T cells, CD 4 cells cross the endothelial cell barrier by
diapedesis. These cells take up the lipoproteins and form foam cells.
This causes proliferation of smooth muscle cells  and induces the
extracellular matrix to form a thick fibrous cap over the atherosclerotic
vascular lesion.
The cells involved in the formation of atherosclerotic
plaques stimulate many inflammatory mediators . These mediators
contribute to the development, instability of the atherosclerotic
palques and its eventual rupture.
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III. CRP
CRP is one of the many acute phase reactants, present in the
atherosclerotic vascular lesion and more specifically in the vascular
intimal layer of the vessel. This localization makes it a major player
directly in the development of atherosclerotic process (32). CRP is a
phylogenetically highly conserved plasma proteins belong to a
member of the pentraxin family. This protein was originally observed
to 1930 in the plasma of patients with acute infection, where it react
with the C-polysaccharide of pneumococcus and hence the name C
reactive protein..
CRP present in plasma is produced by liver where the synthesis of
regulated by IL 6 which in turn is controlled by other inflammatory
cytokines such as IL 1 and TNF alpha.
NITRIC OXIDE EXPRESSION
CRP has been known to affect the expression and bio activity of
endothelial NO synthase. Its increased serum level causes decreased activity of
endothelial NO synthase which results in reduced bioavailability of Nitric Oxice
(NO) and hence a decreased vasodilatory effect. This makes CRP a pro
atherogenic and prothrombotic . CRP induces platet adhesion to endothelial
cells. CRP is also chemotactic for human blood monocytes.
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EXPRESSION OF INFLAMMATORY MEDIATORS OF CYTOKINES,
CHEMOKINES AND ADHESION MOLECULES:
CRP causes elevation of inflammatory cytokines in relation to its level.
Hence a high level of CRP induces a more increase in inflammatory cytokines.
CRP induces release of IL 6 and IL 1 and TNF alpha. All three cytokine were
detected 4 hours after CRP elevation with maximum level of TNF alpha at 8
hours and IL 1 & 6 at 16 hours. In atherosclerotic lesions CRP directly
upregulates mRNA expression of the macrophage marker CD 2B and HLA DR
as well as their protein products.
FRAMINGHAM STUDY(15)
To study the correlation between the baseline CRP level and risk of
subsequent stroke events, CRP assay was done in member of Framingham
study, original cohort, who were free of stroke or TIA at the time of 1980 to
1982 clinical examination and studied the baseline CRP plasma concentration to
the incident of first ever stroke or TIA in their subjects during 12-14 years
follow up. The date derived from the outcome of this study demonstrated a
progressive increase in the incidence of TIA and ischaemic stroke with
increased level of CRP.
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CRP levels are known to be greater in smokers, obese individuals with
(BMI>130% of ideal) and individuals with subclinical atherosclerosis. All of
these afore mentioned aee individual risk factor of adverse cerebrovascular or
cardiovascular events. But in a trend analysis, showed the relationship between
the increased TIA and incidence of stroke  with increased level of CRP
persisted even after adjusting for a number of potential confounder.
In the Framingham study the data were obtained in a elderly cohort of
men and women and led to the conclusion that the elevated level of CRP
significantly predicted the greater risk of ischaemic stroke or TIA in elderly
men and women.
PROGNOSTIC INFLUENCE OF INCREASED CRP AFTER FIRST EVER
ISCHAEMIC STROKE
In their study Ridler and colleagues found an association between evidence of
inflammation after myocardial infarction and increased risk of recurrent cerebral
events.
This encourages Mario Di Nepoli and Co to conduct a study (7)
On the role of CRP level in short term prognosis after first ever ischaemic
stroke. About 30 ischaemic stroke patient of either gender (combined) with age
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group 49-90 years were studies within 4 weeks of the occurrence of the first
ever CVD ischaemic events. No patients with evidence of acute infections were
included in the series CRP was collected with in a medium of 14 days from
stroke event. It was foud that patient with highest CRP level >5mg/dl at study
entry died or had severe complications after stroke such as pulmonary embolism
or had no evidence of  recovery during the two months follow up.
This study concluded that CRP was increased in patients with cerebral
ischaemia, the higher level correlating with significant neurological deficit and
relevant disability and appear to provide additional information regarding
prognosis after ischaemic stroke, as it appears to do after myocardial infarction.
PROGNOSTIC INFLUENCE OF INCREASED CRP AND FIBRINOGEN IN
ISCHAEMIC STOKE
Mario Di Napoli and co also did a study to investigate and compare the
influence of fibrinogen and CRP level in the prognosis of ischaemic stoke in
one year. This led two conclusions.
1. Increased level of CRP are clearly related with poor prognosis in
patients with ischaemic stroke and
2. Increased risk related with elevated CRP and prognostic influence of
the fibrinogen are independent of one another.
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INFLAMMATION AND STROKE, THE LEIDEN 85 PLUS STUDY (21)
All citizens of Leiden, Netherlands, who were 85 years old were visited
at their residence (response rate was 87%) and their levels of the anti
inflammatory cytokines IL 10 were assessed in a whole blood assay. In this
study lipopolysaccharide was used as a stimulation. CRP serum level was also
used as a marker of inflammation. A history of stroke was obtained at base line
(prevalence 10%). The number of fatal stoke was prospectively obtained for a
median follow up of 2.6 years (incidence 1.8/100 persons yearial rule). Subject
with a history of stroke has significantly lower median IL 10 production level at
base line done subject without stroke. They also had higher median CRP
concentration. High CRP plasma  concentration are directly related with an
increased risk of stroke.
CRP AND OUTCOME AFTER FIRST EVER ISCHAEMIC STROKE(9)
Dr. Keith W. Muir, department of neurology, institute of neurological
science,southern general hospital Glasgow, conducted a study in which Patients
admitted to an acute stroke unit serving a catchment population of 2,26,000
were taken and the survival time and cause of death for upto 4 years after the
index stroke were assessed and related to CRP concentrations assayed within 72
hours of stroke and prognostic variables by a COX proportional hazards
regression model. Ischaemic stroke was diagnosed in 228 of 283 consecutive
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admissions. Median follow up was 959 days geometric mean, CRP
concentration was 10.1mg/L. survival window with CRP >10.1mg/L was
significantly worse than with CRP < 10.1mg/L. higher CRP concentration was
an independent predictor of mortality and morbidity together age and stroke
severity on the national institute of  health stroke scale.
CRP MORBIDITY PREDICTOR IN ISCHAEMIC STROKE(23)
Dr. H.N. Panicker, M. Thomes and Co conducted a prospective hospital
based study of 105 patients of ischemic stroke in department of neurology. The
focal neurological and functional core was assessed along with the CRP serum
level. Then the patients were followed up ad 5 days and after 6 months and the
outcome was studied. The functional status was assessed by Barthel Index by
activities of daily living. Based on this the patients were divided in to two
groups. Barthel Index <41 are brought under severly disabled group, 41-60  are
grouped under moderately disabled and > 60 are grouped under mildly disabled.
The results showed that if there is aphasia or the upper limb power of grade 4
along with elevated CRP level these patients showed higher di ability and
belonged to severely disabled group. If there is no aphasia or upper limb power
grade 3 or more with no elevation of CRP, these patients belonged to mildly
disable dgroup at 6 months. Conclusion was patient can be stratified according
to the predicted  prognosis.
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CRP AND INFARCT SIZE
In patients with ischaemic stroke the extent of necrosis is major factor
but not then only determinant of morbidity. Various prognostic studies showed
that CRP concentration were increased (>5mg/dl) in patients with large infarct
size with worst outcome. Similarly with smaller infarct the elevatins of CRP
were also smaller.
The strong association of elevated levels of serum CRP is clinically
supported with quantitative analysis of cerebral infarction by CT scan of brain.
This infarction is an acute phase response to inflammatory stimulus and is
directly proportional to the inflammatory stimulus.
TROPONIN T AND ISCHAEMIC STROKE
The connection between brain and heart was highlited in early 20th
century when Levy et al showed that ischemic changes in central nercous
system and its metabolism influenced cardiac fuction. Later this report was
supported by many other reports that have been published regarding the
importance of the hypothalamus in controlling cardiac activity especially
function of the sinus node and rythm. Morphological ECG canges of
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repolarization type occur when the hypopthalamus and other related parts of the
brain are stimulated experimentally.
In 1947 the first clinical study on ECG changes in brain dysfunction was
published and in 1950s and 60s several reports regarding the same findings in
intracerebral hemorrhage, subarachnoid haemorrhage,  and ischaemic strokes
were published.
Dysarhythmias and repolarisation disturbances occurring in stroke may
be caused by catecholamines released into the systemic circulation secondary to
direct neuronal effects mediated from CNS via neurons ending on the heart or
co existing heart diseases. These may cause elevated levels of cardiac specific
troponin T. Infact it has been clear that in many stroke cases there is
concomitant increase in the serum concentrations of troponins in serum
indicating coronary disease.
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TROPONINS
Troponins are intracellular proteins in all muscle cells. In cardiac muscles
also there are troponins proteins. These proteins are released into circulation
when there is any injury to the muscle cells. Measuring these proteins may be
useful in evaluating the extent of injury. Most useful of these proteins are
troponin T and Troponin I. measuring these cardiac specific troponins gives a
picture of the extent of injury to cardiac muscles. Of this we are measuring the
Troponin T for this study.
This troponin T begins to elevate in 8 – 12 hours reaches peak in 1 – 2
days and remain elevated for 7 – 10 Days of cardiac injury. According to one
school of thought, in ischaemic stroke there may be many micro emboli which
may cause micro infarct in myocardium causing elevation of troponin T. In
studies worldwide troponin T values more than 0.01ng/L is considered positive
for troponin T.
FUNCTIONAL OUTCOME SCALE
Various functional outcome scale attempts to quantify the patients
functional status are measured by ability to perform the task of daily living.
35
GLASGOW OUTCOME SCORE
It is 5 point scale with 1 = dead and 5 = good recovery.
MODIFIED RANKINS SCALE
5 points global assessment categorization of a patients function based on
the ability to perform activities of day living.
ACTIVITIES OF DAILY LIVING SCALE
1. BARTHEL INDEX
Barthel index is a widely used increase of functional outcome.
A score of 100 indicates functional inadequacy, a score of 0
total dependence. If so if below 40 after 3 months of stroke despite
rehabilitation procedures, the chances of patients being independent is
remote. Although it is a measure of alround disability, it takes no
account of vision, hearing and speech.
2. ACTIVITY INDEX
Activity index includes 4 mental capacity items, 6 measures
of motor functions and 5 mesures of activites of daily living.
There is a strong correlation between the activity index and
Barthel index.
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MATERIALS AND METHODS
The study of hs CRP and troponin T in ischaemic stroke was carried out
in the department of medicine, kanyakumari medical college.
SETTINGS
Medical wards
STUDY DESIGN
Single centre observational prospective hospital based study.
PERIOD OF STUDY
October 2014 to September 2015
Kanyakumari government medical college is a tertiary care centre and
referral care centre. All stoke patients admitted in the above period and who are
satisfied set criteria were included.
1. Stroke as define by WHO as a rapidly developing clinical signs of
focal and at times global disturbances of cerebral function lasting
more than 24 hours or leading to death, with no apparent cause other
than that of vascular origin.
2. All patients with CT proven cse of ischaemic stroke.
3. First episodes of ischaemic stroke.
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4. Do not satisfying any of exclusion criteria.
EXCLUSION CRITERIA
1. Age >75 or <15
2. Patients with TIA
3. Patient with previous h/o stroke, TIA
4. Patients with haemorrhagic stroke, tumour, sub arachnoid
haemorrhage.
5. Patients with head injury within 3 months.
6. CT negative stroke.
7. Patient who received aspirin treatment outside.
8. Patient with h/o hypertension, diabetes, heart disease, collagen
disorders, hyperlipidemia, T.B., arteritis were excluded.
9. Smokers were excluded
10.Patients with obesity (BMI >30kg/M2)
11.Patients with major renal, hepatic, cancerous disease.
12.Patients with meningitis, brain abscess, or any chronic infection
that affected CRP value.
13.Those with signs and symptoms of a clinical infection during the
last 4 weeks before onset of stroke.
14.Those with signs and symptoms and clinical evidence of hospital
acquired infection.
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METHODOLOGY
After obtaining verbal consent from either patient or relatives, all patients
in the study group were evaluated by complete medical history, full
neurological examination standardized blood tests and imaging studies.
HISTORY
Clinical history was recorded from either the patient or his/her relatives.
Special emphasis was given to presenting complaint, mode of onset, presence or
absence of serizures, loss of consciousness, headache, vomiting etc. presence or
absence of risk factors, for stroke was also noted. Past history of TIA,
hypertension, diabetes, coronary artery disease, rheumatic heart disease,
collagen disease, tuberculous etc were carefully sought. Personal history
regarding dietary habits, smoking, alcoholic status were noted.
GENERAL EXAMINATION
Apart from routine observations, markers of atherosclerosis like carotid
arteries, status of peripheral vessels, carotid thrill and BP were noted.
CNS EXAMINATION
Each of the patient were examined and assessed according to a predefined
protocol developed for the study. The patients were evaluated thrice during the
course of the disease.
40
The first evaluation was 24 -72 hours after the onset of stoke. A detailed
clinical evaluation was done and recorded. The extent of neurological defect,
cranial nerve palsies, aphasia, gaze palsies, sensory impairment, cerebellar
dysfunction, heminaopia were all recorded along with computed tomography of
brain and levels of hsCRP and troponin T were measured and recorded.
Functional score was assessed based on Barthel Index. HsCRP was measured
using immunoturbidimetry method and Troponin T was done using standard
card test of Roche diagnostics. The patients was again assessed on the 5th day
and condition was reviewed. Proper treatment as according to the protocol was
given along with nursing care and physiotherapy in indicated cases.
Third evaluation was done 4 weeks after the onset of stroke. Any
improvement or worsening of the condition was recorded and functional status
was recorded based on Barthel Index. Any doubts and apprehension of the
patients or the relatives were addressed and importance of proper nursing care
and physiotherapy was emphasised.
Based on the Barthel Index patients were divided into 3 groups.
Barthel index <41 severly disabled.
Barthel index 41 – 60 moderately disabled.
Barthel index >60 mildly disabled.
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BARTHEL INDEX OF ACTIVITY OF DAILY LIVING
1. Feeding 10 = independent.
5 =  needs help i.e forcutting
0 =  inferior performance
2. Bathing 5 = performs without assistance
0 =  inferior performance
3. Personal toilet 5 = washes face, combs hair, brushes teeth
0 =  inferior performance
4. Dressing 10 = independent
5 = needs help
0 =  inferior performance
5. Bowel control 10 = no accidents
5 = occasional accidents
0 =  inferior performance
6. Bladder control 10 = no accidents
5 = occasional accidents
0 =  inferior performance
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7. Toilet transfer 10 = independent with toilet or bed pan
5 = needs help for balance
0 =  inferior performance
8. Chair / bed transfers 15 = independent
10 = minimum assistance
5 = able to sit, needs assistance to transfer
0 =  inferior performance
9. Ambulation 15 = independent for 50 yards
10 = with help for 50 yards
5 = independent with wheel chair
0 =  inferior performance
10.Stair climbing 10 = independent
5 = needs help or supervision
0 =  inferior performance
Maximum disability  =  0
Minimum disability  =  100
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PRINCIPLES AND METHODS
In our study hs-CRP was determined by immunoturbidimetric method
PRINCIPLES OF IMMUNOTURBIDIMETRY:
This method is based on the principle that when an antigen and antibody
is allowed to react  they agglutinate and form a precipitate in the sample which
is measured by a laser and the exact value of the antigen can be estimated. Here
the antigen is CRP and the anti CRP antibody that is sensitized with latex
particles are used. The agglutinated is pounded upon with a laser beam of
570nm. The magnitude of change in penetration of the laser is directly
proportional to the quantity of CRP in the sample. The actual concentration then
determined from a predefined calibration curve prepared by the calibrators with
known concentration.
INTERPRETATION OF VALUES:
<1mg/L = Mild elevation of CRP
1 – 3 mg/L = moderate elevation of CRP
>3mg/L = high elevation of CRP.
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TROPONIN T:
For the estimation of Troponin T, standard card test by Roche
diagnostics, COBAS card is used.
METHOD:
Patients blood dample is collected by phlebotomy and mixed with EDTA.
The EDTA mixed blood about 100 microliter is taken using a micro pipette and
placed in the well provided in the card and wait for 15 minutes.
The result should be read exactly at 15 min. positivity is indicated by two
lines – control and test. Negativity is indicated by single line. If the card reads
positive, the value of Troponin T is >0.1ng/ml and if the card reads negative,
the serum value of troponin is <0.1ng/ml.
After obtaining all the necessaryparameters, a detailed analysis of
date was performed. Univariate analysis was done by chi square test and
multivariate analysis by logistic regression.
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AGE
Age Frequency Percent Valid Percent Cumulative Percent
Valid
35 1 1 1 1
40 1 1 1 2
44 1 1 1 3
45 2 2 2 5
46 1 1 1 6
49 2 2 2 8
50 2 2 2 10
52 4 4 4 14
53 3 3 3 17
54 1 1 1 18
55 6 6 6 24
56 5 5 5 29
57 2 2 2 31
58 10 10 10 41
59 3 3 3 44
60 4 4 4 48
47
61 1 1 1 49
62 5 5 5 54
63 4 4 4 58
64 2 2 2 60
65 11 11 11 71
66 3 3 3 74
67 2 2 2 76
69 1 1 1 77
70 3 3 3 80
72 5 5 5 85
73 3 3 3 88
74 3 3 3 91
75 2 2 2 93
77 1 1 1 94
78 1 1 1 95
79 2 2 2 97
82 1 1 1 98
85 2 2 2 100
Total 100 100 100
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SEX
.SEX
Frequency Percent Valid
Percent Cumulative Percent
Valid
E 1 1 1 1
F 35 35 35 36
M 64 64 64 100
Total 100 100 100
APHASIA
APHASIA
Frequency Percent ValidPercent Cumulative Percent
Valid
1 65 65 65 65
2 35 35 35 100
Total 100 100 100
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APHASIA
APHASIA
Frequency Percent ValidPercent Cumulative Percent
Valid
- 62 62 62 62
+ 38 38 38 100
Total 100 100 100
CONJUGATE DEVIATION
CONJUGATE GAZE DEVIATION
Frequency Percent ValidPercent Cumulative Percent
Valid
0 62 62 62 62
1 38 38 38 100
Total 100 100 100
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CONJUGATE DEVIATION
CONJUGATE GAZE DEVIATION
Frequency Percent ValidPercent Cumulative Percent
Valid
- 62 62 62 62
+ 38 38 38 100
Total 100 100 100
HSCRP +VE
.HSCRP+ve
Frequency Percent ValidPercent Cumulative Percent
Valid
0 62 62 62 62
1 38 38 38 100
Total 100 100 100
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HSCRP -VE
.HSCRP-ve
Frequency Percent ValidPercent Cumulative Percent
Valid
- 56 56 56 56
+ 44 44 44 100
Total 100 100 100
TROP T +VE
TROT T +VE
Frequency Percent ValidPercent Cumulative Percent
Valid
0 56 56 56 56
1 44 44 44 100
Total 100 100 100
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TROP T -VE
TROP T -VE
Frequency Percent ValidPercent
Cumulative
Percent
Valid
<41 44 44 44 44
>60 8 8 8 52
41-60 48 48 48 100
Total 100 100 100
BARTHEL INDEX
BARTHEL INDEX
Frequency Percent ValidPercent
Cumulative
Percent
Valid
<41 44 44 44 44
>60 8 8 8 52
41 to
60 48 48 48 100
Total 100 100 100
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FREQUENCY TABLE
AGE
Particular
No.of respondents
(n=100)
Percentage
(100%)
Below 40yrs 2 2.0
41 to 50yrs 8 8.0
51 to 60yrs 38 38.0
61 to 70yrs 32 32.0
71yrs & above 20 20.0
SEX
Particular
No.of respondents
(n=100)
Percentage
(100%)
Male 64 64.0
Female 36 36.0
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APHASIA
Particular
No.of respondents
(n=100)
Percentage
(100%)
Negative 62 62.0
Positive 38 38.0
CONJUGATE GAZE DEVIATION
Particular
No.of respondents
(n=100)
Percentage
(100%)
Negative 62 62.0
Positive 38 38.0
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HSCRP
Particular
No.of respondents
(n=100)
Percentage
(100%)
Negative 56 56.0
Positive 44 44.0
TROP T
Particular
No.of respondents
(n=100)
Percentage
(100%)
Negative 81 81.0
Positive 19 19.0
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BARTHEL INDEX
Particular
No.of respondents
(n=100)
Percentage
(100%)
Below 41 44 44.0
41 to 60 48 48.0
61 & above 8 8.0
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CONJUGATE GAZE DEVIATION
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Negative
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TROP T (+Ve/-Ve)
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BARTHEL INDEX
61 & above
41 to 60
Below 41
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Chi-Square Tests
SEX
Statistical
inference
Male Female Total
(n=64) (100%) (n=36) (100%) (n=100) (100%)
APHASIA
Negative 40 62.5% 22 61.1% 62 62.0% X2=.019
Df=1
.891>0.05
Not
Significant
Positive 24 37.5% 14 38.9% 38 38.0%
CONJUGATE
GAZE
DEVIATION
Negative 40 62.5% 22 61.1% 62 62.0%
X2=..019
Df=1
.891>0.05
Not
Significant
Positive 24 37.5% 14 38.9% 38 38.0%
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HSCRP
Negative 35 54.7% 21 58.3% 56 56.0% X2=..124
Df=1
.724>0.05
Not
Significant
Positive 29 45.3% 15 41.7% 44 44.0%
TROP T
(+Ve/-Ve)
Negative 53 82.8% 28 77.8% 81 81.0% X2=..379
Df=1
.538>0.05
Not
Significant
Positive 11 17.2% 8 22.2% 19 19.0%
BARTHEL INDEX OUTCOME AFTER 4 WEEKS
Below 41 28 43.8% 16 44.4% 44 44.0% X2=..831
Df=2
.660>0.05
Not
Significant
41 to 60 32 50.0% 16 44.4% 48 48.0%
61 & above 4 6.3% 4 11.1% 8 8.0%
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Chi-Square Tests
BARTHEL INDEX
Statistical
inference
Below 41 41 to 60
61 &
above
Total
44 100.0% 48 100.0% 8 100.0% 100 100.0%
APHASIA
Negative 14 31.8% 40 83.3% 8 100.0% 62 62.0% X2=31.188
Df=2
.000<0.05
Significant
Positive 30 68.2% 8 16.7% 0 .0% 38 38.0%
CONJUGATE
GAZE
DEVIATION
Negative 14 31.8% 40 83.3% 8 100.0% 62 62.0%
X2=31.188
Df=2
.000<0.05
Significant
Positive 30 68.2% 8 16.7% 0 .0% 38 38.0%
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HSCRP
Negative 14 31.8% 34 70.8% 8 100.0% 56 56.0% X2=21.014
Df=2
.000<0.05
Significant
Positive 30 68.2% 14 29.2% 0 .0% 44 44.0%
TROP T
(+Ve/-Ve)
Negative 35 79.5% 38 79.2% 8 100.0% 81 81.0% X2=18.042
Df=2
.019<0.05
Significant
Positive 9 20.5% 10 20.8% 0 .0% 19 19.0%
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BARTHEL INDEX OUTCOME AFTER 4 WEEKS
BARTHEL
INDEX
<41 >41 Total ChiSquare test
hsCRP +ve 30 14 44 P = 0.11846
>0.05Trop T +ve 9 10 19
Total 39 24 63
Statistics
AGE Mean Median S.D Mini. Max.
61.88 62.00 9.551 35 85
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DISCUSSION
100 patient s  satisfied all the above criteria were included
Males 64
Females 36
The following observations were made out of the 100 patients
44 were hsCRP +ve
19 were trop T +ve
1. % level of hsCRP + in males is 45.3
% level of hsCRP + in females 41.7
For the above data we did Chi square test
X2 = .724 p value > 0.05. So sex does not influence the hsCRP value of
the patient.
2. There is no association between the age of patient and hsCRP x2= 0.674
here also P value >0.05. So age factor does not influence the group
pattern.
3. Severe disability is more in hsCRP +ve compared to – ve group.
4. All patients who had aphasia at the time of admission were hsCRP +ve
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5. All patients who had conjugate gaze deviation were hsCRP +ve and
belong to severely disabled group. Follow up was done at the end of 4
weeks and the following observation made during follow up. Barthel
index at day 1 was found to correlate with that at 4 weeks.
6. During the follow up 68.2% of the hsCRP +ve belonged to severely
disabled group.  29.2% of the hsCRP +ve belonged to moderately
disabled group.
7. All the persons in mildly disabled group were hsCRP –ve.
8. If at admission the uperlimb power is less than MRC grade 4 or aphasia
or conjugate gaze deviation was present, these patients belonged to the
severely diabled group.
9. If at admission the upperlimb or lower limb power was greater than MRC
grade 3 or no aphasia or hsCRP – ve, then at 6 months these patients
belonged to the mildly disabled group.
10.% level of Trop T + in males is 17.2
% level of Trop T + in females 22.2
For the above data we did Chi square test
X2 = .538 P VALUE > 0.05. So sex does not influence the trop t value of the
patient
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11.There is an association between the age of patient and Trop T x2= 0.0
here also P value >0.05. So age factor does influence the group pattern.
12.Severe disability is more in Trop T +ve compared to – ve group.
13.50% of patients who had aphasia at the time of admission were Trop T
+ve
14.50% patients who had conjugate gaze deviation were Trop T +ve and
belong to severely disabled group. Follow up was done at the end of 4
weeks and the following observation made during follow up. Barthel
index at day 1 was found to correlate with that at 4 weeks.
15.During the follow up 20.5% of the Trop T +ve belonged to severely
disabled group.  20.8% of the Trop T +ve belonged to moderately
disabled group.
16.All the persons in mildly disabled group were Trop T –ve.
17.If at admission the uperlimb power is less than MRC grade 4 or aphasia
or conjugate gaze deviation was present, these patients belonged to the
severely diabled group.
18.68.2% of the severely disabled group are hsCRP +ve and 20.5% of the
severly disabled group are Trop T +ve and doing the Chi square test for
these values show P 0.1185 which is >0.05 and hence either hsCRP or
Troponin T test have no better significance in predicting the morbidity
outcome in ischaemic stroke.
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CONCLUSION
1. hsCRP & Trop T+ve is increased in a significant fraction of ischaemic
stroke.
2. Increase in hsCRP & Trop T is independent of age.
3. Increase in hsCRP is independent of sex.
4. But Trop T is dependent on age elevated in old age.
5. Patients with increased hsCRP & Trop T+ve had invariably more deficit
during admission.
6. Patients with low hsCRP & Trop T –ve had mild deficit during admission
and have good prognostic outcome at 4 weeks after onset of stroke.
7. Patients with increased hsCRP & Trop T+ve had severe disability when
compared with patients with normal levels, 4 weeks after onset of stroke.
8. hsCRP and Trop T has no better advantage over one another in predicting
the morbidity in ischaemic stroke, but Trop T card test is cheaper the
hsCRP assay can be taken into consideration.
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PROFORMA
Name: Ward:
Age: Unit:
Sex: IP No:
Date of admission:
Address
Complaints:
History of present illness:
Mode of onset:
Activity at the time of onset:
Time of onset:
Associated symptoms:
Head ache, vomiting, loss of consciousness, seizures
Past
Family history
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General examination
Pulse:
BP:
CNS Examination:
Hemiparesis
Speech
Power
Conjugate gaze deviation
Barthel index
Risk factors
Obesity
Diabetes mellitus
Hypertension
Ischaemic heart disease
Smoker
Alcoholism
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Hypercholesterolemia
INVESTIGATIONS
Blood sugar
Urea
Creatinine
Lipid profile
CT scan Brain
VDRL
HS CRP
Troponin T
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Sl.N
o: NAME
AG
E
SE
X
APHAS
IA
CONJUGAT
E
GAZE
DEVIATIO
N
HSCR
P
TRO
P T
BARTH
EL
INDEX
1 RAMANI 72 M + + + + <41
2 DURAISAMY 65 M + + + - <41
3 ANGAMMAL 62 F + + + - <41
4 SELVIN 65 M + + + - <41
5 SELVARAJ 62 M - - - - 41-60
6
THANUMALAY
AN 62 M - - - - 41-60
7 VENKATESH 73 M - - - + 41-60
8 AMEENA BEEVI 55 F - - - - 41-60
9 MANIKANDAN 59 M + + + - <41
10 ANNAMAL 58 F - - - - 41-60
11 RANI 77 F - - - + 41-60
12
MUTHUKRISHN
AN 56 M + + - - 41-60
13 GOPI 52 M + + + - <41
14 VENKATESH 52 M - - + - 41-60
15 PUSHPAM 53 F + + + - <41
16 SAROJA 65 F - - - - 41-60
17 KALIAPPAN 66 M - - - - 41-60
18 KADARKARAI 58 M + + + - <41
19 MANGAMMAL 63 F - - - - 41-60
20 SELVAMMAL 75 F - - - + 41-60
21 SUDALAI 50 M - - + - 41-60
22 RAVI 65 M - - - - 41-60
23 SHANTAMMAL 56 F + + + - <41
24 MAHESWARI 55 F - - - - 41-60
25
LAKSHMIAMM
AL 49 F - - - - >60
26 ANTHONY 62 M - - - - 41-60
27 SAMUEL 61 M - - - - 41-60
28 JEYARANAI 57 F - - + - 41-60
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29 KASTHURI 74 F - - - + 41-60
30 SANKARI 58 F + + + - <41
31 GURUVAMMAL 52 F + + + - 41-60
32
KASTHURIREN
GAN 63 M - - - - <41
33
SHENBAGARAJ
AN 79 M - - - - 41-60
34 PERUMAL 35 M + + + - <41
35 PERUMAL 60 M + + + + 41-60
36 POOVAMMAL 45 F - - - - <41
37
SHENBAGARAJ
AN 58 M - - - - >60
38 ALAGARSAMY 70 M + + + - <41
39 MURUGAN 44 M - - - - >60
40 THANGAM 70 M + + + + 41-60
41 RAJASEKAR 45 M - - - - <41
42 TIRUVAIMOZHI 53 M - - - - <41
43 ESAKITHEVAR 60 M + + + - <41
44 JANAKI 55 F + + + - <41
45 RAMRAJ 40 M - - - - >60
46 PAULRAJ 55 M - - - - <41
47 ARUMUGAM 57 M - - - - <41
48 SANKARAN 46 M - - - - <41
49 RAMASAMY 85 M + + + + <41
50 ALWAR 50 M - - + - 41-60
51 MUTHUSAMY 65 M + + + - <41
52 SUCHINDRAN 65 M + + + - <41
53
THANGAMUTH
U 67 F + + + + <41
54 BAGAVATHY 74 E + + + + <41
55 LOURDUMARY 58 F - - - - 41-60
56
CHARLES
THANGAM 69 M - - - - 41-60
57 JEBA SINGH 55 M + + - - 41-60
58 KANNIMARIAL 72 F + + + + <41
59 SUDHAGARAN 65 M - - + - 41-60
60 KANCHANA 59 F + + + - <41
61 NAGARAJAN 70 M - - - + 41-60
62 GEETHA 72 F - - - - 41-60
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63
ANTHONY
MUTHU 54 M - - - - 41-60
64 SRIDHARAN 64 M + + + - <41
65 ESAKKIMUTHU 58 M - - - - 41-60
66 DAVID RAJA 65 F - - - - 41-60
67 CHARLES 56 M - - - - 41-60
68
CHANDRASEKA
R 85 M + + + + <41
69 KEERTHANA 60 F - - - - 41-60
70 SAVERIYAR 53 M - - - - 41-60
71 BENEDICT 79 M - - - + 41-60
72 MOSES 60 M - - - - 41-60
73 BENJITHSON 52 M - - + - 41-60
74 CHRISTY 66 F - - - - 41-60
75
ANANDA
NADAR 58 M + + + - <41
76 MURALIDARAN 65 M - - + + 41-60
77 PRADEEPAN 59 M - - - - 41-60
78
THANUPERUM
AL 72 M + + + - <41
79 THABASI 62 M - - - - 41-60
80 MARGARET 56 F - - - - >60
81
LAKSHMIAMM
AL 65 F - - - - <41
82 SURESH 58 M - - - - >60
83
DHANALAKSH
MI 63 F + + + - <41
84 RADHIKA 65 F - - - - >60
85 SIVARAMAN 78 M + + + + 41-60
86
ANADAGIRIVAS
AN 58 M + + + - 41-60
87 EUGIN 75 F - - - - <41
88 GURUVAMMAL 58 F - - - - 41-60
89 ROBINSON 73 M + + + + <41
90
SINGAPERUMA
L 56 M + + + - 41-60
91
SENTHIL
KUMAR 64 M - - - - <41
92 THOMSUN 55 M - - - - <41
89
93 BAGAHAVTHY 74 F + + + + <41
94 AROCKIAMARY 82 F + + + - <41
95 SUSEELA 49 F - - - - >60
96 THANGAPPAN 63 M - - - - <41
97 SORNAM 73 M - - - - <41
98 RAMANI 66 M - - - - <41
99 SIVAGAMI 72 F + + + + <41
100 SRIDARAN 67 M - - + - 41-60
90
91
92
93
